Literature DB >> 33451073

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis.

Francesco Paolo Busardò1, Ana Pilar Pérez-Acevedo2,3, Roberta Pacifici4, Giulio Mannocchi5, Massimo Gottardi6, Esther Papaseit2,3, Clara Pérez-Mañá2,3, Soraya Martin2, Lourdes Poyatos2,3, Simona Pichini4, Magí Farré2,3.   

Abstract

Inhalation by vaporization is a useful application mode for medical cannabis. In this study, we present the disposition of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors, and their metabolites in serum, oral fluid, and urine together with the acute pharmacological effects in 14 healthy individuals treated with vaporized medical cannabis. THC and CBD peaked firstly in serum and then in oral fluid, with higher concentrations in the first biological matrices and consequent higher area under the curve AUCs. Acidic precursors Δ-9-tetrahydrocannabinolic acid A (THCA) and cannabidiolic acid (CBDA) showed a similar time course profile but lower concentrations due to the fact that vaporization partly decarboxylated these compounds. All THC and CBD metabolites showed a later onset with respect to the parent compounds in the absorption phase and a slower decrease to baseline. In agreement with serum kinetics, THC-COOH-GLUC and 7-COOH-CBD were the significantly most excreted THC and CBD metabolites. The administration of vaporized medical cannabis induced prototypical effects associated with the administration of cannabis or THC in humans, with a kinetic trend overlapping that of parent compounds and metabolites in serum. The pharmacokinetics of cannabinoids, their precursors, and their metabolites in biological fluids of individuals treated with vaporized medical cannabis preparations showed a high interindividual variability as in the case of oral medical cannabis decoction and oil. Inhaled medical cannabis was absorbed into the organism earlier than decoction and oil. Cannabinoids reached higher systemic concentrations, also due to the fact that the acid precursors decarboxylated to parent cannabinoids at high temperatures, and consequently, the physiological and subjective effects occurred earlier and resulted with higher intensity. No serious adverse effects were observed.

Entities:  

Keywords:  cannabidiol; cannabidiol metabolism; cannabis; medical cannabis

Year:  2021        PMID: 33451073      PMCID: PMC7828520          DOI: 10.3390/ph14010059

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  30 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

2.  A UHPLC-MS/MS method for the quantification of Δ9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis.

Authors:  Sebastiano Barco; Carmen Fucile; Luca Manfredini; Elisa De Grandis; Marcella Gherzi; Antonietta Martelli; Gino Tripodi; Francesca Mattioli; Giuliana Cangemi
Journal:  Bioanalysis       Date:  2018-11-06       Impact factor: 2.681

3.  Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.

Authors:  Roberta Pacifici; Emilia Marchei; Francesco Salvatore; Luca Guandalini; Francesco Paolo Busardò; Simona Pichini
Journal:  Clin Chem Lab Med       Date:  2017-08-28       Impact factor: 3.694

4.  Human Pharmacology of Mephedrone in Comparison with MDMA.

Authors:  Esther Papaseit; Clara Pérez-Mañá; Julián-Andrés Mateus; Mitona Pujadas; Francina Fonseca; Marta Torrens; Eulàlia Olesti; Rafael de la Torre; Magí Farré
Journal:  Neuropsychopharmacology       Date:  2016-05-20       Impact factor: 7.853

5.  Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis.

Authors:  Ana P Pérez-Acevedo; Roberta Pacifici; Giulio Mannocchi; Massimo Gottardi; Lourdes Poyatos; Esther Papaseit; Clara Pérez-Mañá; Soraya Martin; Francesco P Busardò; Simona Pichini; Magí Farré
Journal:  Phytother Res       Date:  2020-11-06       Impact factor: 5.878

6.  Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.

Authors:  Simona Pichini; Giulio Mannocchi; Massimo Gottardi; Ana Pilar Pérez-Acevedo; Lourdes Poyatos; Esther Papaseit; Clara Pérez-Mañá; Magí Farré; Roberta Pacifici; Francesco Paolo Busardò
Journal:  Talanta       Date:  2019-11-15       Impact factor: 6.057

7.  Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy.

Authors:  Marcella Gherzi; Giulia Milano; Carmen Fucile; Maria Grazia Calevo; Maria Margherita Mancardi; Lino Nobili; Pietro Astuni; Valeria Marini; Sebastiano Barco; Giuliana Cangemi; Luca Manfredini; Francesca Mattioli; Elisa De Grandis
Journal:  Complement Ther Med       Date:  2020-04-28       Impact factor: 2.446

8.  An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.

Authors:  Tine van de Donk; Marieke Niesters; Mikael A Kowal; Erik Olofsen; Albert Dahan; Monique van Velzen
Journal:  Pain       Date:  2019-04       Impact factor: 7.926

9.  Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes.

Authors:  Francesca Baratta; Marco Simiele; Irene Pignata; Lorenzo Ravetto Enri; Riccardo Torta; Anna De Luca; Massimo Collino; Antonio D'Avolio; Paola Brusa
Journal:  Front Pharmacol       Date:  2019-06-25       Impact factor: 5.810

10.  A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation.

Authors:  Nadia Solowij; Samantha J Broyd; Hendrika H van Hell; Arno Hazekamp
Journal:  BMC Pharmacol Toxicol       Date:  2014-10-16       Impact factor: 2.483

View more
  5 in total

Review 1.  Acidic Cannabinoid Decarboxylation.

Authors:  Crist N Filer
Journal:  Cannabis Cannabinoid Res       Date:  2021-09-22

2.  Current state of cannabis use, policies, and research across sixteen countries: cross-country comparisons and international perspectives.

Authors:  Ramdas Ransing; Pedro A de la Rosa; Victor Pereira-Sanchez; Jibril I M Handuleh; Stefan Jerotic; Anoop Krishna Gupta; Ruta Karaliuniene; Renato de Filippis; Eric Peyron; Ekin Sönmez Güngör; Said Boujraf; Anne Yee; Bita Vahdani; Sheikh Shoib; M J Stowe; Florence Jaguga; Lisa Dannatt; Alexandre Kieslich da Silva; Paolo Grandinetti; Chonnakarn Jatchavala
Journal:  Trends Psychiatry Psychother       Date:  2022-07-14

3.  Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations.

Authors:  Lyndsey L Anderson; Maia G Etchart; Dilara Bahceci; Taliesin A Golembiewski; Jonathon C Arnold
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

4.  Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users.

Authors:  Nunzia La Maida; Esther Papaseit; Lucia Martínez; Clara Pérez-Mañá; Lourdes Poyatos; Manuela Pellegrini; Simona Pichini; Roberta Pacifici; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Magí Farré
Journal:  Biology (Basel)       Date:  2021-03-24

5.  UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations.

Authors:  Sara Malaca; Massimo Gottardi; Federica Pigliasco; Sebastiano Barco; Alessia Cafaro; Elisabetta Amadori; Antonella Riva; Martina Marcenaro; Pasquale Striano; Giuliana Cangemi; Roberta Pacifici; Simona Pichini; Francesco Paolo Busardò
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.